Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Yamamoto (Chiba, Japan), R. Nishimura (Chiba, Japan), A. Naito (Chiba, Japan), F. Kato (Shizuoka, Japan), R. Suda (Chiba, Japan), T. Jujo Sanada (Chiba, Japan), S. Sakao (Chiba, Japan), N. Tanabe (Chiba, Japan), K. Tatsumi (Chiba, Japan). Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension. 4946

Member's Comments

No comment yet.

Related content which might interest you: Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Endothelial progenitor cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 435s Year: 2004 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 Circulating endothelial progenitor cells and chronic pulmonary diseases Source: Eur Respir J 2011; 37: 426 Year: 2011 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Endothelial progenitors in pulmonary hypertension Source: Annual Congress 2011 - Bone marrow-derived stem cells in respiratory diseases: a future therapy? Year: 2011 Decreased glycolysis as metabolic footprint of endothelial cells in chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Platelets and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Endothelial dysfunction of patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 LSC - 2020 - Comparison of metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Source: Eur Respir J 2014; 44: 1275-1288 Year: 2014 Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012